ConductScience.org, home

Paper468786

Nucleation-controlled aggregation of deoxyhemoglobin S. Possible difference in the size of nuclei in different phosphate concentrations.

Adachi K and 1 other. J Biol Chem, 1979. Cited by 115 papers, by iCite.

Cite this record

ConductScience Library. Nucleation-controlled aggregation of deoxyhemoglobin S. Possible difference in the size of nuclei in different phosphate concentrations. Papers, record 468786. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/468786

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Nucleation-controlled aggregation of deoxyhemoglobin S. Possible difference in the size of nuclei in different phosphate concentrations.
PubMed
Journal
J Biol Chem
PubMed
Year
1979
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
115
iCite
Relative citation ratio, by iCite
3.15
iCite
Revised in PubMed
2021-02-10
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Adachi KK
2Asakura TT

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hemoglobin, SickleMajor topic
Humans
Kinetics
Osmolar Concentration
Protein Binding
Spectrophotometry
Temperature

Source PubMed

Download CSV of topics

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 115 citations.

PMIDTitleJournalYearIn PapersSource
39920120Base editing HbS to HbG-Makassar improves hemoglobin function supporting its use in sickle cell disease.Nat Commun2025https://conductscience.org/library/papers/39920120PubMed
34510823Caffeic acid: an antioxidant with novel antisickling properties.FEBS Open Bio2021https://conductscience.org/library/papers/34510823PubMed
33661300MetAP2 inhibition modifies hemoglobin S to delay polymerization and improves blood flow in sickle cell disease.Blood Adv2021https://conductscience.org/library/papers/33661300PubMed
30630954Substitutions in the β subunits of sickle-cell hemoglobin improve oxidative stability and increase the delay time of sickle-cell fiber formation.J Biol Chem2019https://conductscience.org/library/papers/30630954PubMed
28770911Targeting βCys93 in hemoglobin S with an antisickling agent possessing dual allosteric and antioxidant effects.Metallomics2017https://conductscience.org/library/papers/28770911PubMed
26187468Sickle Cell Hemoglobin with Mutation at αHis-50 Has Improved Solubility.J Biol Chem2015https://conductscience.org/library/papers/26187468PubMed
17493634Metastable polymerization of sickle hemoglobin in droplets.J Mol Biol2007https://conductscience.org/library/papers/17493634PubMed
17350155The role of beta93 Cys in the inhibition of Hb S fiber formation.Biophys Chem2007https://conductscience.org/library/papers/17350155PubMed
17131194Pair-wise interactions of polymerization inhibitory contact site mutations of hemoglobin-S.Protein J2006https://conductscience.org/library/papers/17131194PubMed
16819835Inhibition of hemoglobin S polymerization in vitro by a novel 15-mer EF-helix beta73 histidine-containing peptide.Biochemistry2006https://conductscience.org/library/papers/16819835PubMed
15465861Aggregation of normal and sickle hemoglobin in high concentration phosphate buffer.Biophys J2004https://conductscience.org/library/papers/15465861PubMed
12124399A human embryonic hemoglobin inhibits Hb S polymerization in vitro and restores a normal phenotype to mouse models of sickle cell disease.Proc Natl Acad Sci U S A2002https://conductscience.org/library/papers/12124399PubMed
10827998Solubility of fluoromethemoglobin S: effect of phosphate and temperature on polymerization.Biophys J2000https://conductscience.org/library/papers/10827998PubMed
10096916Sickle hemoglobin polymer melting in high concentration phosphate buffer.Biophys J1999https://conductscience.org/library/papers/10096916PubMed
9172771Solubility of sickle hemoglobin measured by a kinetic micromethod.Biophys J1996https://conductscience.org/library/papers/9172771PubMed
7937904Recombinant human hemoglobins designed for gene therapy of sickle cell disease.Proc Natl Acad Sci U S A1994https://conductscience.org/library/papers/7937904PubMed
7670370Mutational analysis of phenylalanine beta 85 in the valine beta 6 acceptor pocket during hemoglobin S polymerization.Protein Sci1995https://conductscience.org/library/papers/7670370PubMed
6498276Kinetics of nucleation-controlled polymerization. A perturbation treatment for use with a secondary pathway.Biophys J1984https://conductscience.org/library/papers/6498276PubMed
6256747
Proton longitudinal relaxation investigation of histidyl residues of normal human adult and sickle deoxyhemoglobin: evidence for the existence of pregelation aggregates in sickle deoxyhemoglobin solutions.
Proc Natl Acad Sci U S A1980https://conductscience.org/library/papers/6256747PubMed
3242632Kinetics of domain formation by sickle hemoglobin polymers.Biophys J1988https://conductscience.org/library/papers/3242632PubMed

See all 23 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/468786

GET https://conductscience.org/api/papers/v1/468786/cited_by?page=2